Skip to main content
. Author manuscript; available in PMC: 2016 Dec 22.
Published in final edited form as: Methods Enzymol. 2016 Feb 23;573:261–278. doi: 10.1016/bs.mie.2016.01.020

Fig. 4.

Fig. 4

Structures of representative LSD1 inhibitors. Bizine, a selective phenelzine analog (top);NCL1, a tranylcypromine analog (middle); and GSK2879552, a recent tranylcypromine analog (bottom), have been shown to be potent and selective LSD1 inhibitors.